JOSEPH R III HYDE

CIK 903352 · Chairman · last filed 2019-01-03

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$264.40M

Companies

3

Total Filings

144

Lifetime Open-Market Net

$24.61M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Oncternal Therapeutics, Inc. (GTXI) Delisted Director 4,229,013 $24.61M 86 2019-01-03
AZO Director 73,930 $3064.48 $226.56M $0 50 2018-01-02
FDX Director 116,000 $326.20 $37.84M $0 8 2010-09-29

Recent Filings · Page 8 of 15

144 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2011-01-03 AZO Grant (A) +183 $50.0K EDGAR
2010-12-15 AZO Mixed −17,000 $84.1K EDGAR
2010-12-01 AZO Grant (A) $0 EDGAR
2010-11-03 Oncternal Therapeutics, Inc. (GTXI) Delisted Buy (P) +5,467,857 $15.31M EDGAR
2010-10-04 Oncternal Therapeutics, Inc. (GTXI) Delisted Grant (A) +2,616 $9.0K EDGAR
2010-09-29 FDX Grant (A) $0 EDGAR
2010-09-01 AZO Grant (A) $0 EDGAR
2010-07-06 Oncternal Therapeutics, Inc. (GTXI) Delisted Grant (A) +2,950 $9.0K EDGAR
2010-06-17 Oncternal Therapeutics, Inc. (GTXI) Delisted $0 EDGAR
2010-06-09 Oncternal Therapeutics, Inc. (GTXI) Delisted Buy (P) +210,272 $546.7K EDGAR
Showing 7180 of 144
Page 8 of 15
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.